Hemostemix Inc.

HMTXF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$2,616-$2,502-$5,235-$6,286
Dep. & Amort.$0$0$0$1
Deferred Tax$0$0$487-$256
Stock-Based Comp.$331$150$179$362
Change in WC-$232$555-$1,705$2,815
Other Non-Cash$615$378$173-$114
Operating Cash Flow-$1,902-$1,420-$6,102-$3,478
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$171
Investing Cash Flow$0$0$0$171
Financing Activities
Debt Repay.$0$0$2,750$2,500
Stock Issued$2,452$1,505$3,452$840
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$65-$184-$72
Financing Cash Flow$2,452$1,439$6,018$3,268
Forex Effect$0$0$0$0
Net Chg. in Cash$550$20-$84-$39
Supplemental Information
Beg. Cash$155$136$219$258
End Cash$706$155$136$219
Free Cash Flow-$1,902-$1,420-$6,102-$3,478
Hemostemix Inc. (HMTXF) Financial Statements & Key Stats | AlphaPilot